CN111870629A - 一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 - Google Patents
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 Download PDFInfo
- Publication number
- CN111870629A CN111870629A CN202010822620.9A CN202010822620A CN111870629A CN 111870629 A CN111870629 A CN 111870629A CN 202010822620 A CN202010822620 A CN 202010822620A CN 111870629 A CN111870629 A CN 111870629A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- skin diseases
- prepared
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 51
- 208000017520 skin disease Diseases 0.000 title claims abstract description 29
- 241000270295 Serpentes Species 0.000 title claims abstract description 20
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000219357 Cactaceae Species 0.000 claims abstract description 10
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 10
- SCULJPGYOQQXTK-OLRINKBESA-N Cinobufagin Chemical compound C=1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@H](O)C[C@H]5CC[C@H]4[C@@]43O[C@@H]4[C@@H]2OC(=O)C)C=CC(=O)OC=1 SCULJPGYOQQXTK-OLRINKBESA-N 0.000 claims abstract description 10
- SCULJPGYOQQXTK-UHFFFAOYSA-N Cinobufagin Natural products CC(=O)OC1C2OC22C3CCC4CC(O)CCC4(C)C3CCC2(C)C1C=1C=CC(=O)OC=1 SCULJPGYOQQXTK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 10
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 10
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 10
- 241000218681 Pseudolarix Species 0.000 claims abstract description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 10
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 10
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 10
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 10
- 241001521901 Tribulus lanuginosus Species 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000269420 Bufonidae Species 0.000 claims abstract description 8
- 241001048891 Jatropha curcas Species 0.000 claims abstract description 7
- 241000972672 Phellodendron Species 0.000 claims abstract description 4
- 244000061520 Angelica archangelica Species 0.000 claims abstract 4
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229940057995 liquid paraffin Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 241000972673 Phellodendron amurense Species 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 3
- 241000130993 Scarabaeus <genus> Species 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 229960002152 chlorhexidine acetate Drugs 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 241000212948 Cnidium Species 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 206010017533 Fungal infection Diseases 0.000 abstract description 3
- 208000031888 Mycoses Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 206010003399 Arthropod bite Diseases 0.000 abstract description 2
- 206010013786 Dry skin Diseases 0.000 abstract description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 abstract description 2
- 206010040943 Skin Ulcer Diseases 0.000 abstract description 2
- 208000002474 Tinea Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000003088 amphibian venom Substances 0.000 abstract description 2
- 230000037336 dry skin Effects 0.000 abstract description 2
- 231100000019 skin ulcer Toxicity 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000003612 virological effect Effects 0.000 abstract description 2
- 208000002003 vulvitis Diseases 0.000 abstract description 2
- 241000130764 Tinea Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 13
- 239000005556 hormone Substances 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 241000125175 Angelica Species 0.000 description 6
- 241000219061 Rheum Species 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 201000004681 Psoriasis Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000269368 Xenopus laevis Species 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229940100615 topical ointment Drugs 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 201000010618 Tinea cruris Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Animal Husbandry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及治疗皮肤病的外用软膏技术领域,尤其涉及一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏。该一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成蛇床子70‑90份;地肤子40‑60份;苦参70‑90份;防风20‑40份;白鲜皮40‑60份;凤仙草20‑40份;大疯子40‑60份;当归40‑60份;红花10‑30份;土槿皮40‑60份;刺蒺藜20‑40份;华蟾皮10‑30份;蜂房10‑30份;大黄40‑60份;冰片70‑90份;仙人掌40‑60份;黄柏20‑40份。本发明一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,主要治疗皮肤癣类疾病,皮炎,真菌感染,皮肤干燥、皲裂、病毒性疱疹、皮肤溃疡、蚊虫叮咬、红肿热痛、外阴炎瘙痒等皮肤病,使用后吸收快、疗效好且稳定,未见任何毒副作用,适用范围广等优点。
Description
技术领域
本发明涉及治疗皮肤病的外用软膏技术领域,尤其涉及一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏。
背景技术
皮炎是临床较为常见的疾病,根据世界变应性组织推荐使用的皮炎分类方式,皮炎分为湿疹、接触性皮炎、其他类型皮炎。目前对于皮炎治疗药物,西医主要采用的多是皮质激素类药物,内服抗组胺及抗生素类药物。然而近年来,由于外用激素制剂引发的皮肤损害急剧增加,不良反应显著,成为人们高度关注的社会问题。长期外用激素可导致骨质疏松、免疫力低下、真菌感染、皮肤萎缩、色素沉着、毛细血管扩张、烧灼感、萎缩纹、多毛、痤疮及酒渣鼻样皮疹。
激素对各种原因(如感染、过敏、物理因子等)引起的皮肤炎症有明显的非特异性抑制作用,外用后虽可使病情迅速改善,但它只是短期缓解症状,抑制炎症反应,而不是治愈炎症,不能从根本上治疗病因。激素的滥用,还可导致激素依赖性皮炎发生,一旦停药就会复发或恶化。当重新外用激素后,上述症状或者体征很快消退,再度停药,迅速再发,且比前次更加剧烈,一般药物难以控制。西药抗生素的应用是皮肤科的主要治疗手段,但是在应用的过程中滥用的现象愈演愈烈,这不仅造成了药品的严重浪费,还增加细菌耐药性的产生,对社会造成了巨大的危害。
中医治疗皮炎主要采用的是口服汤剂,外用洗剂的结合疗法,虽然避免了各种西医的不合理用药导致的病变,药物依赖等,但是口服汤剂口感苦涩,对于小儿的服用更是存在难度,治疗不方便。由此,同时避免西药使用中可能导致的病变和药物依赖,又能避免中药口服汤剂口感苦涩的药物亟待研制。
发明内容
针对现有技术的上述缺陷,本发明提供的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,解决了上述技术问题。
为了达到上述目的,本发明提供如下技术方案:
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子70-90份;地肤子40-60份;苦参70-90份;防风20-40份;白鲜皮40-60份;凤仙草20-40份;大疯子40-60份;当归40-60份;红花10-30份;土槿皮40-60份;刺蒺藜20-40份;华蟾皮10-30份;蜂房10-30份;大黄40-60份;冰片70-90份;仙人掌40-60份;黄柏20-40份。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子82份;地肤子49份;苦参82份;防风32份;白鲜皮57份;凤仙草32份;大疯子49份;当归49份;红花25份;土槿皮49份;刺蒺藜32份;华蟾皮25份;蜂房25份;大黄49份;冰片80份;仙人掌49份;黄柏32份。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子70份;地肤子40份;苦参72份;防风25份;白鲜皮44份;凤仙草25份;大疯子45份;当归40份;红花15份;土槿皮44份;刺蒺藜25份;华蟾皮15份;蜂房15份;大黄60份;冰片70份;仙人掌47份;黄柏25份。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏包括如下制备方法:
步骤一:将上述原料破碎,置于酒精中浸泡30-60分钟;
步骤二:对浸泡后的原料进行蒸馏,蒸馏出酒精存留药液;
步骤三:再把原料药渣用水泡18-30小时,再熬制2-3小时;
步骤四:在加入酒精混合,进行蒸馏,制得药液;
步骤五:加入备好的药膏基质制成膏。
其中,所述步骤四中制成药粉。
其中,所述步骤五中加凡士林、液体石蜡制软膏成品。
其中,所述药膏基质为原料组成及其重量份数的原料制成:甘油5份;硬脂酸3份;十八醇8份;单甘脂6份;液状石蜡4份;水47份。
其中,制备软膏步骤五中加入皮肤消毒剂醋酸氯已定粉,灭菌备用。
本发明的有益效果是:本发明提供的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,主要治疗牛皮癣、体癣、股癣、手足癣、头癣,痈疽、毒疮、脂肪瘤、疥疮、湿疹、丘疹瘙痒、神经性皮炎、过敏性皮炎、真菌感染、皮肤干燥、皲裂、病毒性疱疹、皮肤溃疡、蚊虫叮咬、红肿热痛、外阴炎瘙痒等皮肤病。使用后吸收快、疗效好且稳定,未见任何毒副作用,适用范围广等优点。
为了能更进一步了解本发明的特征以及技术内容,请参阅以下有关本发明的详细说明。
具体实施方式
为更进一步阐述本发明所采取的技术手段及其效果,以下结合本发明的优选实施例进行详细描述。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子70-90份;地肤子40-60份;苦参70-90份;防风20-40份;白鲜皮40-60份;凤仙草20-40份;大疯子40-60份;当归40-60份;红花10-30份;土槿皮40-60份;刺蒺藜20-40份;华蟾皮10-30份;蜂房10-30份;大黄40-60份;冰片70-90份;仙人掌40-60份;黄柏20-40份。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏包括如下制备方法:
步骤一:将上述原料破碎,置于酒精中浸泡45分钟;
步骤二:对浸泡后的原料进行蒸馏,蒸馏出酒精存留药液;
步骤三:再把原料药渣用水泡24小时,再熬制2.5小时;
步骤四:在加入酒精混合,进行蒸馏,制得药液;
步骤五:加入备好的药膏基质制成膏。
实施例1:
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子82份;地肤子49份;苦参82份;防风32份;白鲜皮57份;凤仙草32份;大疯子49份;当归49份;红花25份;土槿皮49份;刺蒺藜32份;华蟾皮25份;蜂房25份;大黄49份;冰片80份;仙人掌49份;黄柏32份。
实施例2:
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏由以下重量份数的原料制成:蛇床子70份;地肤子40份;苦参72份;防风25份;白鲜皮44份;凤仙草25份;大疯子45份;当归40份;红花15份;土槿皮44份;刺蒺藜25份;华蟾皮15份;蜂房15份;大黄60份;冰片70份;仙人掌47份;黄柏25份。
一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏包括如下制备方法:
步骤一:将上述原料破碎,置于酒精中浸泡30-60分钟;
步骤二:对浸泡后的原料进行蒸馏,蒸馏出酒精存留药液;
步骤三:再把原料药渣用水泡18-30小时,再熬制2-3小时;
步骤四:在加入酒精混合,进行蒸馏,制得药液;
步骤五:加入备好的药膏基质制成膏。
具体的,所述步骤四中制成药粉。
具体的,所述步骤五中加凡士林、液体石蜡制软膏成品。
具体的,所述药膏基质为原料组成及其重量份数的原料制成:甘油5份;硬脂酸3份;十八醇8份;单甘脂6份;液状石蜡4份;水47份。
具体的,制备软膏步骤五中加入皮肤消毒剂醋酸氯已定粉,灭菌备用。
本发明中原料进行酒精提纯、水提纯后,蒸馏掉酒精成分,浓缩取药液,用软膏基质制成软膏;或用提取设备提取药材精油,再加用赋形剂成膏。
经过提纯后的药材成分,保持了一定的药性及纯度,便于皮肤吸收和效期内的稳定保存。
在制备软膏过程中,或直接用药材精油提取设备,提取药材主要成分后,制膏方法可采用二种:1、根据药性选择药材可破壁细粉液体石蜡加凡士林成稿;2、酒精提取后,去掉70%酒精,药膏基质成膏。
典型案例:
张某、男、48岁。患牛皮癣16年,多发,主要以下肢及背部为主。治疗:口服中药多菌肽粉,一日3次,一次10克,配合外用“凤蟾蛇油膏”病灶区外擦,一日3次。外擦软膏前先用多菌肽粉剂药浴30分钟,药浴结束30分钟后,冲洗身体擦干后再涂擦本发明专利软管,泡浴初期两天一次,软膏每日三次涂用。观察:类似病例一般用发明专利软管外涂治疗,一般一周内退掉牛皮癣,退掉后继续按一日2次涂擦,并服用中药或多菌肽2-3个疗程即可治愈。本例患者总治愈时间2个疗程,至今5年未见复发。
李女士37岁严重脚气(真菌)感染四个月,脚周脚气严重其痒,抓破,起皮,多次复发,各种治疗及大中小医院都治疗过,中医药、外用药也都治疗过,但毫无效果。患者用本发明产品发明专利软管,四天治愈,跟踪回访一年半再无复发!
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (8)
1.一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,由以下重量份数的原料制成蛇床子70-90份;地肤子40-60份;苦参70-90份;防风20-40份;白鲜皮40-60份;凤仙草20-40份;大疯子40-60份;当归40-60份;红花10-30份;土槿皮40-60份;刺蒺藜20-40份;华蟾皮10-30份;蜂房10-30份;大黄40-60份;冰片70-90份;仙人掌40-60份;黄柏20-40份。
2.根据权利要求1所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,由以下重量份数的原料制成:蛇床子82份;地肤子49份;苦参82份;防风32份;白鲜皮57份;凤仙草32份;大疯子49份;当归49份;红花25份;土槿皮49份;刺蒺藜32份;华蟾皮25份;蜂房25份;大黄49份;冰片80份;仙人掌49份;黄柏32份。
3.根据权利要求1所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,由以下重量份数的原料制成:蛇床子70份;地肤子40份;苦参72份;防风25份;白鲜皮44份;凤仙草25份;大疯子45份;当归40份;红花15份;土槿皮44份;刺蒺藜25份;华蟾皮15份;蜂房15份;大黄60份;冰片70份;仙人掌47份;黄柏25份。
4.根据权利要求1所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,包括如下制备方法:
步骤一:将上述原料破碎,置于酒精中浸泡30-60分钟;
步骤二:对浸泡后的原料进行蒸馏,蒸馏出酒精存留药液;
步骤三:再把原料药渣用水泡18-30小时,再熬制2-3小时;
步骤四:在加入酒精混合,进行蒸馏,制得药液;
步骤五:加入备好的药膏基质制成膏。
5.根据权利要求4所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,所述步骤四中制成药粉。
6.根据权利要求5所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,所述步骤五中加凡士林、液体石蜡制软膏成品。
7.根据权利要求4所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,所述药膏基质为原料组成及其重量份数的原料制成:甘油5份;硬脂酸3份;十八醇8份;单甘脂6份;液状石蜡4份;水47份。
8.根据权利要求4所述的一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏,其特征在于,制备软膏步骤五中加入皮肤消毒剂醋酸氯己定粉,灭菌备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010822620.9A CN111870629A (zh) | 2020-08-14 | 2020-08-14 | 一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010822620.9A CN111870629A (zh) | 2020-08-14 | 2020-08-14 | 一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111870629A true CN111870629A (zh) | 2020-11-03 |
Family
ID=73202748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010822620.9A Pending CN111870629A (zh) | 2020-08-14 | 2020-08-14 | 一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111870629A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101269163A (zh) * | 2008-05-03 | 2008-09-24 | 马建国 | 一种治疗慢性湿疹的药膏及其制备方法 |
CN102204981A (zh) * | 2010-03-29 | 2011-10-05 | 中国人民解放军第二军医大学 | 一种抗皮炎湿疹的中药复方洗剂 |
CN108478647A (zh) * | 2018-07-06 | 2018-09-04 | 彭石浓 | 一种用于皮肤病的中药组合物及其制剂、制备方法与用途 |
CN109568194A (zh) * | 2017-09-29 | 2019-04-05 | 俞有芳 | 一种苦参洗浴液及制备方法 |
-
2020
- 2020-08-14 CN CN202010822620.9A patent/CN111870629A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101269163A (zh) * | 2008-05-03 | 2008-09-24 | 马建国 | 一种治疗慢性湿疹的药膏及其制备方法 |
CN102204981A (zh) * | 2010-03-29 | 2011-10-05 | 中国人民解放军第二军医大学 | 一种抗皮炎湿疹的中药复方洗剂 |
CN109568194A (zh) * | 2017-09-29 | 2019-04-05 | 俞有芳 | 一种苦参洗浴液及制备方法 |
CN108478647A (zh) * | 2018-07-06 | 2018-09-04 | 彭石浓 | 一种用于皮肤病的中药组合物及其制剂、制备方法与用途 |
Non-Patent Citations (4)
Title |
---|
徐培焜: "复方百部洗剂治疗手足癣与湿疹95例疗效观察", 《新中医》 * |
杨文治,等: "钟传华主任治疗肛门湿疹经验", 《云南中医中药杂志》 * |
罗美兰,等: "复方苦蛇黄洗剂质量标准", 《中国实验方剂学杂志》 * |
陈菊: "中药治疗肛门直肠疾病手术后并发症120例", 《辽宁中医学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nasri et al. | Medicinal plants for the treatment of acne vulgaris: a review of recent evidences | |
Vogler et al. | Aloe vera: a systematic review of its clinical effectiveness. | |
US6027728A (en) | Herbal skin regeneration composition and method | |
CN102579709B (zh) | 一种防疤消痕烧伤油及其制备方法 | |
CN104524469A (zh) | 一种跌打药酒 | |
CN108245602B (zh) | 一种治疗皮肤病的外用中药组合物 | |
CN111870629A (zh) | 一种基于调理皮肤疾病的外用涂擦凤蟾蛇油软膏 | |
CN108186497B (zh) | 一种激素脸修护精华液及其制备方法和应用 | |
CN109453327A (zh) | 一种具有祛痘功效的中药组合物及其水提物和发酵物以及应用 | |
CN1175841C (zh) | 一种治癣止痒的中药制剂 | |
Safdari et al. | Using complementary and alternative medicines to prevent and treat pressure ulcers: A systematic review | |
CN108815475B (zh) | 治疗皮肤炎症的中药药膏及其制备方法 | |
CN105596488A (zh) | 一种治疗牛皮癣的药物组合物及其制备方法 | |
CN111821414A (zh) | 一种中药止痒喷剂及其制备方法 | |
CN1278712C (zh) | 一种中药抗真菌软膏及其制备方法 | |
CN103908558A (zh) | 一种治疗痤疮的中药组合物及其制备方法和应用 | |
CN112972578A (zh) | 一种治疗牛皮癣的膏剂及其制备方法 | |
CN106344548A (zh) | 治疗皮肤病的外用药物 | |
CN1269511C (zh) | 一种护肤中药 | |
Vibhooti et al. | Fight psoriasis naturally through ayurveda | |
CN109331106B (zh) | 用于创面修复的红药制剂及其制备方法 | |
CN105560837A (zh) | 治疗皮肤损伤的药物及其制备方法 | |
CN107050298A (zh) | 一种治疗烧烫伤皮损的中药膏配方及制备方法 | |
CN1239180C (zh) | 一种治疗痔疮的药物 | |
CN111759903A (zh) | 一种治疗牛皮癣的中药膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201103 |
|
RJ01 | Rejection of invention patent application after publication |